Insider trade

Officer reported a gift or transfer of 1,538 REGN shares

Traded Oct 30, 2025 · Filed Oct 31, 2025

Regeneron PharmaceuticalsREGN

1,538
Shares

Why it stands out

Gift or transfer — classified separately from trades.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Oct 30, 2025
Reporting period: Not applicable
Filed with the SEC: Oct 31, 2025

OfficerGift / transfer

Context

Classification

gift transfer

Code G — gift, bequest or transfer

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001796226-25-000005
Filed / recorded

Oct 31, 2025, 8:06 PM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

REGENERON PHARMACEUTICALS, INC.

Issuer CIK

872589

Ticker

REGN

Reporting person

Andrew J Murphy

Relationship

Officer

Officer title

EVP Research

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Oct 30, 2025

Transaction code

G

Shares / units

1,538

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

50,046

Ownership form

Direct

Amendment

No

Around the same time

11mo ago

14KDerivative units

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

11mo ago

760Shares · @ $371.40

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

Director sold ~$570K of Regeneron Pharmaceuticals

Scheduled in advance11mo ago